{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,23]],"date-time":"2026-07-23T15:26:57Z","timestamp":1784820417037,"version":"3.55.0"},"reference-count":27,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2009,1,1]],"date-time":"2009-01-01T00:00:00Z","timestamp":1230768000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["The Veterinary Journal"],"published-print":{"date-parts":[[2009,1]]},"DOI":"10.1016\/j.tvjl.2007.08.034","type":"journal-article","created":{"date-parts":[[2007,12,3]],"date-time":"2007-12-03T19:06:28Z","timestamp":1196708788000},"page":"70-77","source":"Crossref","is-referenced-by-count":33,"title":["Clinical evaluation of pimecrolimus eye drops for treatment of canine keratoconjunctivitis sicca: A comparison with cyclosporine A"],"prefix":"10.1016","volume":"179","author":[{"given":"Ron","family":"Ofri","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"George N.","family":"Lambrou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ingrid","family":"Allgoewer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Uwe","family":"Graenitz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Teresa M.","family":"Pena","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bernhard M.","family":"Spiess","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elisabeth","family":"Latour","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.tvjl.2007.08.034_bib1","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1111\/j.1463-5224.2005.00390.x","article-title":"Effect of topical 0.02% tacrolimus aqueous suspension on tear production in dogs with keratoconjunctivitis sicca","volume":"8","author":"Berdoulay","year":"2005","journal-title":"Veterinary Ophthalmology"},{"key":"10.1016\/j.tvjl.2007.08.034_bib2","first-page":"5","article-title":"Effects of ophthalmic cyclosporine on lacrimal gland pathology and function in dogs with keratoconjunctivitis sicca","volume":"5","author":"Bounous","year":"1995","journal-title":"Veterinary and Comparative Ophthalmology"},{"key":"10.1016\/j.tvjl.2007.08.034_bib3","doi-asserted-by":"crossref","first-page":"1153","DOI":"10.1067\/mai.2003.1492","article-title":"Elidel (pimecrolimus) cream 1%: a nonsteroidal topical agent for the treatment of atopic dermatitis","volume":"111","author":"Eichenfield","year":"2003","journal-title":"Journal of Allergy and Clinical Immunology"},{"key":"10.1016\/j.tvjl.2007.08.034_bib4","doi-asserted-by":"crossref","first-page":"264","DOI":"10.1046\/j.1365-2133.1999.02974.x","article-title":"A novel anti-inflammatory drug, SDZ ASM 981, for the treatment of skin diseases: in vitro pharmacology","volume":"141","author":"Grassberger","year":"1999","journal-title":"British Journal of Dermatology"},{"key":"10.1016\/j.tvjl.2007.08.034_bib5","first-page":"5","article-title":"The tear film in the dog. Causes and treatment of diseases associated with overproduction and underproduction of tears","volume":"15","author":"Helper","year":"1996","journal-title":"Animal Eye Research"},{"key":"10.1016\/j.tvjl.2007.08.034_bib6","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1046\/j.1365-2249.2002.01962.x","article-title":"Pimecrolimus inhibits up-regulation of OX40 and synthesis of inflammatory cytokines upon secondary T cell activation by allogeneic dendritic cells","volume":"130","author":"Kalthoff","year":"2002","journal-title":"Clinical and Experimental Immunology"},{"key":"10.1016\/j.tvjl.2007.08.034_bib7","first-page":"1073","article-title":"Rheumatoid factor determination of 50 dogs with keratoconjunctivitis sicca","volume":"183","author":"Kaswan","year":"1983","journal-title":"Journal of the American Veterinary Medical Association"},{"key":"10.1016\/j.tvjl.2007.08.034_bib8","first-page":"112","article-title":"Keratoconjunctivitis sicca: histopathologic study of nictitating membrane and lacrimal glands from 28 dogs","volume":"45","author":"Kaswan","year":"1984","journal-title":"American Journal of Veterinary Research"},{"key":"10.1016\/j.tvjl.2007.08.034_bib9","first-page":"376","article-title":"Keratoconjunctivitis sicca: immunological evaluation of 62 canine cases","volume":"46","author":"Kaswan","year":"1985","journal-title":"American Journal of Veterinary Research"},{"key":"10.1016\/j.tvjl.2007.08.034_bib10","first-page":"93","article-title":"Interaction of age and gender on occurrence of canine keratoconjunctivitis sicca","volume":"1","author":"Kaswan","year":"1991","journal-title":"Progress in Veterinary and Comparative Ophthalmology"},{"key":"10.1016\/j.tvjl.2007.08.034_bib11","doi-asserted-by":"crossref","first-page":"1114","DOI":"10.1016\/S0161-6420(98)96016-X","article-title":"The epidemiology of dry eye in Melbourne, Australia","volume":"105","author":"McCarty","year":"1998","journal-title":"Ophthalmology"},{"key":"10.1016\/j.tvjl.2007.08.034_bib12","doi-asserted-by":"crossref","first-page":"568","DOI":"10.1111\/j.1365-2133.1997.tb03788.x","article-title":"A novel anti-inflammatory drug, SDZ ASM 981, for the topical and oral treatment of skin diseases: in vivo pharmacology","volume":"137","author":"Meingassner","year":"1997","journal-title":"British Journal of Dermatology"},{"key":"10.1016\/j.tvjl.2007.08.034_bib13","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1046\/j.1523-1747.2003.12331.x","article-title":"Pimecrolimus inhibits the elicitation phase but does not suppress the sensitization phase in murine contact hypersensitivity, in contrast to tacrolimus and cyclosporine A","volume":"121","author":"Meingassner","year":"2003","journal-title":"Journal of Investigative Dermatology"},{"key":"10.1016\/j.tvjl.2007.08.034_bib14","doi-asserted-by":"crossref","first-page":"1649","DOI":"10.1016\/j.jcrs.2004.02.041","article-title":"Changes in ocular aberrations after instillation of artificial tears in dry-eye patients","volume":"30","author":"Montes-Mico","year":"2004","journal-title":"Journal of Cataract and Refractive Surgery"},{"key":"10.1016\/j.tvjl.2007.08.034_bib15","series-title":"Veterinary Ophthalmology","first-page":"583","article-title":"Diseases and surgery of the lacrimal secretory system","author":"Moore","year":"1999"},{"key":"10.1016\/j.tvjl.2007.08.034_bib16","doi-asserted-by":"crossref","first-page":"1043","DOI":"10.2460\/javma.1991.199.08.1043","article-title":"Topical administration of cyclosporine for treatment of keratoconjunctivitis sicca in dogs","volume":"199","author":"Morgan","year":"1991","journal-title":"Journal of the American Veterinary Medical Association"},{"key":"10.1016\/j.tvjl.2007.08.034_bib17","doi-asserted-by":"crossref","first-page":"1264","DOI":"10.1001\/archopht.118.9.1264","article-title":"Prevalence of and risk factors for dry eye syndrome","volume":"118","author":"Moss","year":"2000","journal-title":"Archives of Ophthalmology"},{"key":"10.1016\/j.tvjl.2007.08.034_bib18","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1111\/j.1463-5224.2005.04062.x","article-title":"The effect of topical pimecrolimus on keratoconjunctivitis sicca and chronic superficial keratitis in dogs: results from an exploratory study","volume":"8","author":"Nell","year":"2005","journal-title":"Veterinary Ophthalmology"},{"key":"10.1016\/j.tvjl.2007.08.034_bib19","doi-asserted-by":"crossref","first-page":"1039","DOI":"10.2460\/javma.1991.199.08.1039","article-title":"Clinical evaluation of 1% cyclosporine for topical treatment of keratoconjunctivitis sicca in dogs","volume":"199","author":"Olivero","year":"1991","journal-title":"Journal of the American Veterinary Medical Association"},{"key":"10.1016\/j.tvjl.2007.08.034_bib20","doi-asserted-by":"crossref","first-page":"1513","DOI":"10.1016\/S0161-6420(86)33528-0","article-title":"The autoimmune nature of aqueous tear deficiency","volume":"93","author":"Pflugfelder","year":"1986","journal-title":"Ophthalmology"},{"key":"10.1016\/j.tvjl.2007.08.034_bib21","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1076\/ceyr.19.3.201.5309","article-title":"Altered cytokine balance in the tear fluid and conjunctiva of patients with Sj\u00f6gren\u2019s syndrome keratoconjunctivitis sicca","volume":"19","author":"Pflugfelder","year":"1999","journal-title":"Current Eye Research"},{"key":"10.1016\/j.tvjl.2007.08.034_bib22","doi-asserted-by":"crossref","first-page":"876","DOI":"10.1046\/j.1523-1747.2002.00694.x","article-title":"Pimecrolimus identifies a common genomic anti-inflammatory profile, is clinically highly effective in psoriasis and is well tolerated","volume":"119","author":"Rappersberger","year":"2002","journal-title":"Journal of Investigative Dermatology"},{"key":"10.1016\/j.tvjl.2007.08.034_bib23","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1016\/S0161-6420(99)00176-1","article-title":"Two multicenter, randomized studies of the efficacy and safety of cyclosporine ophthalmic emulsion in moderate to severe dry eye disease","volume":"107","author":"Sall","year":"2000","journal-title":"Ophthalmology"},{"key":"10.1016\/j.tvjl.2007.08.034_bib24","doi-asserted-by":"crossref","first-page":"504","DOI":"10.1136\/vr.137.20.504","article-title":"Treatment of keratoconjunctivitis sicca in dogs with cyclosporine ophthalmic ointment: a European clinical field trial","volume":"137","author":"Sansom","year":"1995","journal-title":"Veterinary Record"},{"key":"10.1016\/j.tvjl.2007.08.034_bib25","doi-asserted-by":"crossref","first-page":"318","DOI":"10.1016\/S0002-9394(03)00218-6","article-title":"Prevalence of dry eye syndrome among US women","volume":"136","author":"Schaumberg","year":"2003","journal-title":"American Journal of Ophthalmology"},{"key":"10.1016\/j.tvjl.2007.08.034_bib26","doi-asserted-by":"crossref","first-page":"967","DOI":"10.1016\/S0161-6420(00)00035-X","article-title":"Efficacy and safety of cyclosporin A ophthalmic emulsion in the treatment of moderate-to-severe dry eye disease: a dose-ranging, randomized trial. The cclosporin A phase 2 study group","volume":"107","author":"Stevenson","year":"2000","journal-title":"Ophthalmology"},{"key":"10.1016\/j.tvjl.2007.08.034_bib27","doi-asserted-by":"crossref","first-page":"643","DOI":"10.1517\/14656566.5.3.643","article-title":"Pimecrolimus for the treatment of inflammatory skin disease","volume":"5","author":"Wolff","year":"2004","journal-title":"Expert Opinion on Pharmacotherapy"}],"container-title":["The Veterinary Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1090023307003024?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1090023307003024?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,2,20]],"date-time":"2024-02-20T00:25:00Z","timestamp":1708388700000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1090023307003024"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,1]]},"references-count":27,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2009,1]]}},"alternative-id":["S1090023307003024"],"URL":"https:\/\/doi.org\/10.1016\/j.tvjl.2007.08.034","relation":{},"ISSN":["1090-0233"],"issn-type":[{"value":"1090-0233","type":"print"}],"subject":[],"published":{"date-parts":[[2009,1]]}}}